GelSana Therapeutics, Inc.

BiotechnologyBiotechnologyBiomaterialsWound Care

📍 Aurora, CO, US• Founded 2020

StreetZero Signal 76

Be the first to signal interest

About GelSana Therapeutics, Inc.

GelSana Therapeutics is a biomaterials company developing novel hydrogel wound dressings designed to reduce inflammation and provide sustained drug delivery for chronic wounds. The company was founded in 2020 and is headquartered in Aurora, Colorado. It operates in the Healthcare & Life Sciences and Biotechnology sectors.

LATEST FUNDINGPrivate Placement

$4.4M

Announced 2026-10-08

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for GelSana Therapeutics, Inc..

Create free account Sign in

Free plan includes 3 full deal profiles every month.

IN THE NEWS

EMPLOYEES—

FOUNDED2020

HQAurora, CO, US

Industry

Biotechnology

Investors

Deming Center Venture Fund MedTech Innovator Innosphere Ventures Mines Venture Fund She's Independent

Key highlights

Developing hydrogel wound dressings to reduce inflammation and enable sustained drug delivery.
Headquartered in Aurora, CO with 5 employees reported in early 2024.
Participated in MedTech Innovator competition and selected from 1,500 applicants.
Multiple grant rounds from HHS noted in addition to VC funding.
Last reported funding includes Seed Round dated March 2026.